We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Palantir
PLTR
$295B
| $5.06M | 0.04% |
37,086
+19,086
| +106% | +$2.24M |
|
402
Estee Lauder
EL
$29B
| $5.05M | 0.04% |
+62,500
| New | +$4.02M |
|
403
Omnicom Group
OMC
$22.7B
| $5.04M | 0.04% |
70,056
-96,935
| -58% | -$7.16M |
|
404
TaskUs
TASK
$506M
| $5.03M | 0.04% |
+300,000
| New | +$4.57M |
|
405
Roivant Sciences
ROIV
$25.2B
| $5.01M | 0.04% |
444,444
| – | – |
|
406
CALL
Airbnb
ABNB
$83.7B
| $5M | 0.04% |
37,800
+900
| +2% | +$114K |
|
407
CALL
Hewlett Packard
HPE
$63.2B
| $5M | 0.04% |
244,474
+8,000
| +3% | +$134K |
|
408
CALL
Regeneron Pharmaceuticals
REGN
$68.8B
| $4.99M | 0.04% |
+9,500
| New | +$5.3M |
|
409
PUT
Procter & Gamble
PG
$343B
| $4.91M | 0.04% |
30,800
-6,900
| -18% | -$1.13M |
|
410
PUT
Medtronic
MDT
$107B
| $4.9M | 0.04% |
56,200
-38,600
| -41% | -$3.27M |
|
|
411
CALL
Nutanix
NTNX
$14.9B
| $4.85M | 0.03% |
63,400
+10,300
| +19% | +$741K |
|
|
CHYM
412
Chime Financial
CHYM
$7.88B
| $4.83M | 0.03% |
+140,000
| New | +$4.61M |
|
413
PUT
Intuitive Surgical
ISRG
$121B
| $4.78M | 0.03% |
8,800
-6,000
| -41% | -$3.14M |
|
|
JOYY
414
JOYY Inc
JOYY
$3.73B
| $4.73M | 0.03% |
+92,994
| New | +$4.12M |
|
415
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $4.72M | 0.03% |
+53,446
| New | +$4.66M |
|
416
PUT
Stryker
SYK
$127B
| $4.71M | 0.03% |
11,900
+1,100
| +10% | +$412K |
|
417
Apple
AAPL
$4.89T
| $4.66M | 0.03% |
22,712
+15,530
| +216% | +$3.14M |
|
418
PUT
BridgeBio Pharma
BBIO
$16.5B
| $4.65M | 0.03% |
107,700
| – | – |
|
419
PUT
Advance Auto Parts
AAP
$3.37B
| $4.65M | 0.03% |
+100,000
| New | +$4.01M |
|
420
CALL
Avis
CAR
$5.63B
| $4.65M | 0.03% |
+27,500
| New | +$2.96M |
|
|
421
PUT
Avis
CAR
$5.63B
| $4.65M | 0.03% |
+27,500
| New | +$2.96M |
|
422
PUT
Dow Inc
DOW
$21.6B
| $4.63M | 0.03% |
+175,000
| New | +$5.09M |
|
|
RUMBW
423
RUM Group Inc Warrant
RUMBW
$12.1M
| $4.63M | 0.03% |
1,492,262
| – | – |
|
424
CALL
Okta
OKTA
$24.1B
| $4.61M | 0.03% |
46,100
+19,800
| +75% | +$2.11M |
|
|
HVII
425
Hennessy Capital Investment Corp VII
HVII
$273M
| $4.57M | 0.03% |
450,000
| – | – |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.